Pfizer claims there is ‘no evidence’ Brisbane cop, 40, who was hospitalised with blood clots got them from taking the Covid vaccine three days before
- Queensland cop rushed to hospital on Wednesday after developing blood clots
- The 40-year-old had received the Pfizer Covid-19 vaccine just three days before
- Under investigation by Queensland Health, Therapeutic Goods Administration
- The officer recently had knee surgery and suffered deep vein thrombosis
- Pfizer said there is no evidence to conclude risk of blood clots from their vaccine
The 40-year-old police officer, who worked patrolling Queensland’s quarantine hotels, received the Pfizer vaccine on Sunday.
He was rushed to a private hospital on Wednesday after developing blood clots and has since been discharged.
Queensland Health and the Therapeutic Goods Administration are investigating, but he is believed to have had recent knee surgery – which heightens the risk of developing clots.
Pfizer said in a statement they had recently carried out a ‘comprehensive assessment of ongoing aggregate safety data’ of their vaccine.
‘(This has) provided no evidence to conclude that arterial or venous thromboembolic events (blood clots), with or without thrombocytopenia, are a risk associated with the use of our Covid-19 vaccine,’ the pharmaceutical giant said.
Pfizer has said there is no evidence to conclude blood clots are a risk associated with their Covid-19 vaccine. Pictured is the Pfizer vaccine
A Queensland police officer working at a quarantine hotel was taken to hospital on Wednesday after developing blood clots three days after receiving the Pfizer vaccine. Pictured is a file image of a paramedic and police officer outside a quarantine hotel in Brisbane
‘This safety database analysis included a review of all adverse events received for the vaccine through to March 27, 2021. Pfizer considers that the benefit-risk profile of (the vaccine) in preventing Covid-19 remains positive.’
Pfizer added it was closely examining the man’s case.
‘The safety of our vaccine is paramount. We closely monitor all reports of possible adverse events following vaccination and collect relevant information to share with the TGA,’ Pfizer said.
‘In Queensland, all adverse events in relation to the Covid-19 vaccines are reported to the Therapeutic Goods Administration,’ a Queensland Health spokesperson said.
‘The TGA will then undertake an assessment and determine whether there is any clinical link to the vaccination.’
Pfizer said it was monitoring all reports of possible adverse events following vaccination. Pictured, a health worker in Melbourne with the Pfizer vaccine
More than 200 million doses of the Pfizer vaccine have been administered globally.
People under 50 are being advised to take the Pfizer vaccine over the AstraZeneca jab amid concerns about rare blood clots with that jab.
So far, three people have developed clots in Australia after being given the AstraZeneca vaccine.
They include 48-year-old Genene Norris who died in NSW last week.
The TGA said her death was likely linked to her vaccination.
Ms Norris had several chronic health conditions when she received the jab on April 8. She became unwell three or four days later before dying on April 15.
The other two who developed blood clots likely linked to their AstraZeneca jab are a woman in Western Australia and a man in Victoria, both in their 40s.
At least 14 people in Australia have had allergic reactions to the Pfizer vaccine.
Johnson & Johnson also halted the rollout of its own vaccine in Europe last week after US officials recommended a pause due to six detected cases of very rare blood clots.